Data / Research funding / California / Dare Bioscience, Inc.
Dare Bioscience, Inc.: 5 NIH awards ($4M), fiscal years 2021 to 2026
Dare Bioscience, Inc. in San Diego, CA is funded under 5 NIH awards ($4M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- UC4EFLZHANH4
- State
- California
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $2,007,831 | December 12, 2023 | November 30, 2026 | FRIEND, DAVID R | reporter.nih.gov |
| A first-in-class product for the clearance of high-risk human papillomaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,000,000 | December 17, 2024 | November 30, 2026 | THURMAN, ANDREA RIES | reporter.nih.gov |
| Therapeutic targeting of FKBP51 for the prevention of stress-induced preterm birth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $384,972 | August 1, 2023 | July 31, 2024 | FRIEND, DAVID R | reporter.nih.gov |
| Subcutaneous insertion and removal of a user-controlled, long-acting, and reversible contraceptive device | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $309,614 | September 21, 2021 | February 28, 2023 | PROOS, ELIZABETH | reporter.nih.gov |
| Defining end-user preferences among US women to optimize the design of a long-acting injectable hormonal contraceptive | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $249,336 | April 1, 2022 | September 30, 2023 | FRIEND, DAVID R | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 2 | $2,016,258 | 0 | $0 |
| 2024 | 1 | $991,573 | 0 | $0 |
| 2023 | 1 | $384,972 | 0 | $0 |
| 2022 | 1 | $249,336 | 0 | $0 |
| 2021 | 1 | $309,614 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Contraception/Reproduction
- Prevention
- Women's Health
- Pediatric
- Perinatal Period - Conditions Originating in Perinatal Period
- Pregnancy
- Preterm, Low Birth Weight and Health of the Newborn
- Translational Research
- Women's Health Research
- Bioengineering
- Maternal Health
- Clinical Research
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.